Targeted CRO Potential upsell opportunities with pharmaceutical and biotech clients in the Greater Boston area, leveraging NovaBioAssays' specialized MS capabilities for drug discovery support, ADC and glycoprotein analysis, and epitope mapping to expand contract research engagement.

ADC & Biosimilar Niche Position NovaBioAssays as the go-to partner for antibody-drug conjugate characterization and biosimilar development using hydrogen deuterium exchange MS, addressing a high-value, growing segment within biotech pipelines.

Quantitative MS Leaders Highlight SRM/MRM expertise for quantitative measurements across small molecules, peptides, and proteins in complex biological matrices to support bioanalytical studies, biomarker quantification, and pharmacokinetic workflows.

Biotech Ecosystem Fit Leverage proximity to Boston biotech clusters and established tech stack to propose rapid-scale MS services, data management, and secure cloud-ready deliverables that align with clients needing timely results and compliant workflows.

Growth & Capacity Communicate sustainable growth potential with NovaBioAssays’ mid-sized team and clear revenue bandwidth, presenting it as a flexible partner capable of expanding scope, from pilot studies to broader MS service suites.